Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label access to denosumab for adults with advanced cancer
jRCT1080221825Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 4, open-label, single-arm trial of denosumab in cancer, sponsored by Daiichi Sankyo Co., Ltd. Started Jun 2012; status: completed.
02
Drugs
denosumab
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT1080221825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221825.